These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29907881)

  • 1. Cortisol facilitates the immune escape of human acute myeloid leukemia cells by inducing latrophilin 1 expression.
    Sakhnevych SS; Yasinska IM; Bratt AM; Benlaouer O; Gonçalves Silva I; Hussain R; Siligardi G; Fiedler W; Wellbrock J; Gibbs BF; Ushkaryov YA; Sumbayev VV
    Cell Mol Immunol; 2018 Nov; 15(11):994-997. PubMed ID: 29907881
    [No Abstract]   [Full Text] [Related]  

  • 2. Hsp90 Inhibition Reduces TLR5 Surface Expression and NF-
    Na BH; Hoang TX; Kim JY
    Biomed Res Int; 2018; 2018():4319369. PubMed ID: 29651431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico analysis of anti-leukemia immune response and immune evasion in acute myeloid leukemia.
    Krupar R; Schreiber C; Offermann A; Lengerke C; Sikora AG; Thorns C; Perner S
    Leuk Lymphoma; 2018 Oct; 59(10):2493-2496. PubMed ID: 29431550
    [No Abstract]   [Full Text] [Related]  

  • 4. Overexpression of the ABCB1 drug transporter in acute myeloid leukemia cells is associated with downregulation of latrophilin-1.
    Kocibalova Z; Guzyova M; Imrichova D; Sulova Z; Breier A
    Gen Physiol Biophys; 2018 May; 37(3):353-357. PubMed ID: 29938681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of functional neuronal receptor latrophilin 1 in human acute myeloid leukaemia cells.
    Sumbayev VV; Gonçalves Silva I; Blackburn J; Gibbs BF; Yasinska IM; Garrett MD; Tonevitsky AG; Ushkaryov YA
    Oncotarget; 2016 Jul; 7(29):45575-45583. PubMed ID: 27322212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of the leukemia-associated antigen SSX2IP predicts survival in acute myeloid leukemia patients who lack detectable cytogenetic rearrangements.
    Guinn B; Greiner J; Schmitt M; Mills KI
    Blood; 2009 Jan; 113(5):1203-4. PubMed ID: 19179477
    [No Abstract]   [Full Text] [Related]  

  • 7. Bortezomib sensitivity of acute myeloid leukemia CD34(+) cells can be enhanced by targeting the persisting activity of NF-κB and the accumulation of MCL-1.
    Bosman MC; Schuringa JJ; Quax WJ; Vellenga E
    Exp Hematol; 2013 Jun; 41(6):530-538.e1. PubMed ID: 23416210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunophenotype of acute myeloid leukemia: is there a relationship with prognosis?
    Mason KD; Juneja SK; Szer J
    Blood Rev; 2006 Mar; 20(2):71-82. PubMed ID: 16185796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADCY7 supports development of acute myeloid leukemia.
    Li C; Xie J; Lu Z; Chen C; Yin Y; Zhan R; Fang Y; Hu X; Zhang CC
    Biochem Biophys Res Commun; 2015 Sep; 465(1):47-52. PubMed ID: 26220344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DNA demethylating agent 5-aza-2'-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells.
    Almstedt M; Blagitko-Dorfs N; Duque-Afonso J; Karbach J; Pfeifer D; Jäger E; Lübbert M
    Leuk Res; 2010 Jul; 34(7):899-905. PubMed ID: 20381863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells.
    Manfredini R; Trevisan F; Grande A; Tagliafico E; Montanari M; Lemoli R; Visani G; Tura S; Ferrari S; Ferrari S
    Cancer Res; 1999 Aug; 59(15):3803-11. PubMed ID: 10446999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukemia: involvement of free radicals.
    Hu ZB; Yang GS; Li M; Miyamoto N; Minden MD; McCulloch EA
    Leukemia; 1995 May; 9(5):789-98. PubMed ID: 7769841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LukS-PV induces mitochondrial-mediated apoptosis and G0/G1 cell cycle arrest in human acute myeloid leukemia THP-1 cells.
    Bu S; Xie Q; Chang W; Huo X; Chen F; Ma X
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1531-7. PubMed ID: 23702031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blasts.
    Gertner-Dardenne J; Castellano R; Mamessier E; Garbit S; Kochbati E; Etienne A; Charbonnier A; Collette Y; Vey N; Olive D
    J Immunol; 2012 May; 188(9):4701-8. PubMed ID: 22467661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of homeobox B6 and B9 genes expression in human leukemia cell lines during myelomonocytic differentiation.
    Ohnishi K; Tobita T; Sinjo K; Takeshita A; Ohno R
    Leuk Lymphoma; 1998 Nov; 31(5-6):599-608. PubMed ID: 9922051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated microRNA-146a expression induced by granulocyte colony-stimulating factor enhanced low-dosage chemotherapy response in aged acute myeloid leukemia patients.
    Li X; Xu L; Sheng X; Cai J; Liu J; Yin T; Xiao F; Chen F; Zhong H
    Exp Hematol; 2018 Dec; 68():66-79.e3. PubMed ID: 30208330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podocalyxin is expressed in normal and leukemic monocytes.
    Riccioni R; Calzolari A; Biffoni M; Senese M; Riti V; Petrucci E; Pasquini L; Cedrone M; Lo-Coco F; Diverio D; Foà R; Peschle C; Testa U
    Blood Cells Mol Dis; 2006; 37(3):218-25. PubMed ID: 17059890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput profiling of signaling networks identifies mechanism-based combination therapy to eliminate microenvironmental resistance in acute myeloid leukemia.
    Zeng Z; Liu W; Tsao T; Qiu Y; Zhao Y; Samudio I; Sarbassov DD; Kornblau SM; Baggerly KA; Kantarjian HM; Konopleva M; Andreeff M
    Haematologica; 2017 Sep; 102(9):1537-1548. PubMed ID: 28659338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional role of BAALC in leukemogenesis.
    Heuser M; Berg T; Kuchenbauer F; Lai CK; Park G; Fung S; Lin G; Leung M; Krauter J; Ganser A; Humphries RK
    Leukemia; 2012 Mar; 26(3):532-6. PubMed ID: 21869843
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidermal growth factor receptor inhibitor cancer drug gefitinib modulates cell growth and differentiation of acute myeloid leukemia cells via histamine receptors.
    Yadav M; Singh AK; Kumar H; Rao G; Chakravarti B; Gurjar A; Dogra S; Kushwaha S; Vishwakarma AL; Yadav PN; Datta D; Tripathi AK; Chattopadhyay N; Trivedi AK; Sanyal S
    Biochim Biophys Acta; 2016 Oct; 1860(10):2178-90. PubMed ID: 27180173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.